Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy

Jinsook Yoon, Soo Hyun Choi, Joon H. Lee, Sung Jun Lee, Sang Yeul Lee

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Purpose: To measure tear nerve growth factor (NGF) concentrations in cases of active thyroid-associated ophthalmopathy (TAO) before and after glucocorticoid treatment, and to correlate NGF levels with disease inflammatory activity and thyroid autoantibody concentration. Methods: The study involved 20 patients with active TAO and 20 age- and gender-matched controls. Tear break-up time (BUT) was obtained, the Schirmer test was performed, and tear NGF/total protein ratio was measured in control subjects and patients with active TAO before, and 2 and 4 weeks after, steroid treatment. Results: Tear BUT and Schirmer values significantly increased after 2 and 4 weeks of steroid treatment (p < 0.001 and p = 0.004 respectively). Baseline tear NGF/total protein ratio was higher in patients with active TAO than in control subjects, and the ratio significantly decreased after 2 and 4 weeks of steroid treatment (p < 0.001). Tear NGF/total protein ratio did not correlate with inflammatory activity score, exophthalmos value and thyroid binding inhibiting immunoglobulin (TBII) level (p > 0.05). Conclusions: Tear NGF may have a specific role in ocular surface inflammation, which protects against ocular surface damage in patients with active TAO. Anti-inflammatory treatment significantly reduced the level of NGF in tears, increased tear film stability and production, and decreased congestive symptoms.

Original languageEnglish
Pages (from-to)271-276
Number of pages6
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume248
Issue number2
DOIs
Publication statusPublished - 2010 Jan 1

Fingerprint

Graves Ophthalmopathy
Nerve Growth Factor
Tears
Inflammation
Steroids
Therapeutics
Autoantibodies
Glucocorticoids
Thyroid Gland
Anti-Inflammatory Agents

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

@article{74562cb038cf412b9bd5932b50efb527,
title = "Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy",
abstract = "Purpose: To measure tear nerve growth factor (NGF) concentrations in cases of active thyroid-associated ophthalmopathy (TAO) before and after glucocorticoid treatment, and to correlate NGF levels with disease inflammatory activity and thyroid autoantibody concentration. Methods: The study involved 20 patients with active TAO and 20 age- and gender-matched controls. Tear break-up time (BUT) was obtained, the Schirmer test was performed, and tear NGF/total protein ratio was measured in control subjects and patients with active TAO before, and 2 and 4 weeks after, steroid treatment. Results: Tear BUT and Schirmer values significantly increased after 2 and 4 weeks of steroid treatment (p < 0.001 and p = 0.004 respectively). Baseline tear NGF/total protein ratio was higher in patients with active TAO than in control subjects, and the ratio significantly decreased after 2 and 4 weeks of steroid treatment (p < 0.001). Tear NGF/total protein ratio did not correlate with inflammatory activity score, exophthalmos value and thyroid binding inhibiting immunoglobulin (TBII) level (p > 0.05). Conclusions: Tear NGF may have a specific role in ocular surface inflammation, which protects against ocular surface damage in patients with active TAO. Anti-inflammatory treatment significantly reduced the level of NGF in tears, increased tear film stability and production, and decreased congestive symptoms.",
author = "Jinsook Yoon and Choi, {Soo Hyun} and Lee, {Joon H.} and Lee, {Sung Jun} and Lee, {Sang Yeul}",
year = "2010",
month = "1",
day = "1",
doi = "10.1007/s00417-009-1215-2",
language = "English",
volume = "248",
pages = "271--276",
journal = "Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie",
issn = "0065-6100",
publisher = "Springer Verlag",
number = "2",

}

Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy. / Yoon, Jinsook; Choi, Soo Hyun; Lee, Joon H.; Lee, Sung Jun; Lee, Sang Yeul.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 248, No. 2, 01.01.2010, p. 271-276.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy

AU - Yoon, Jinsook

AU - Choi, Soo Hyun

AU - Lee, Joon H.

AU - Lee, Sung Jun

AU - Lee, Sang Yeul

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Purpose: To measure tear nerve growth factor (NGF) concentrations in cases of active thyroid-associated ophthalmopathy (TAO) before and after glucocorticoid treatment, and to correlate NGF levels with disease inflammatory activity and thyroid autoantibody concentration. Methods: The study involved 20 patients with active TAO and 20 age- and gender-matched controls. Tear break-up time (BUT) was obtained, the Schirmer test was performed, and tear NGF/total protein ratio was measured in control subjects and patients with active TAO before, and 2 and 4 weeks after, steroid treatment. Results: Tear BUT and Schirmer values significantly increased after 2 and 4 weeks of steroid treatment (p < 0.001 and p = 0.004 respectively). Baseline tear NGF/total protein ratio was higher in patients with active TAO than in control subjects, and the ratio significantly decreased after 2 and 4 weeks of steroid treatment (p < 0.001). Tear NGF/total protein ratio did not correlate with inflammatory activity score, exophthalmos value and thyroid binding inhibiting immunoglobulin (TBII) level (p > 0.05). Conclusions: Tear NGF may have a specific role in ocular surface inflammation, which protects against ocular surface damage in patients with active TAO. Anti-inflammatory treatment significantly reduced the level of NGF in tears, increased tear film stability and production, and decreased congestive symptoms.

AB - Purpose: To measure tear nerve growth factor (NGF) concentrations in cases of active thyroid-associated ophthalmopathy (TAO) before and after glucocorticoid treatment, and to correlate NGF levels with disease inflammatory activity and thyroid autoantibody concentration. Methods: The study involved 20 patients with active TAO and 20 age- and gender-matched controls. Tear break-up time (BUT) was obtained, the Schirmer test was performed, and tear NGF/total protein ratio was measured in control subjects and patients with active TAO before, and 2 and 4 weeks after, steroid treatment. Results: Tear BUT and Schirmer values significantly increased after 2 and 4 weeks of steroid treatment (p < 0.001 and p = 0.004 respectively). Baseline tear NGF/total protein ratio was higher in patients with active TAO than in control subjects, and the ratio significantly decreased after 2 and 4 weeks of steroid treatment (p < 0.001). Tear NGF/total protein ratio did not correlate with inflammatory activity score, exophthalmos value and thyroid binding inhibiting immunoglobulin (TBII) level (p > 0.05). Conclusions: Tear NGF may have a specific role in ocular surface inflammation, which protects against ocular surface damage in patients with active TAO. Anti-inflammatory treatment significantly reduced the level of NGF in tears, increased tear film stability and production, and decreased congestive symptoms.

UR - http://www.scopus.com/inward/record.url?scp=77949270245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949270245&partnerID=8YFLogxK

U2 - 10.1007/s00417-009-1215-2

DO - 10.1007/s00417-009-1215-2

M3 - Article

C2 - 19844736

AN - SCOPUS:77949270245

VL - 248

SP - 271

EP - 276

JO - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

JF - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

SN - 0065-6100

IS - 2

ER -